Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Binary Options?
We'll teach you the best ways to trade binaries.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | 2.91% | 69.00 | 0.0% | $1713.15m | |
| GILD | Gilead Sciences, Inc. | -0.22% | 73.34 | 1.0% | $1486.09m | |
| AMGN | Amgen, Inc. | 0.73% | 226.43 | 1.3% | $647.45m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 1.59% | 569.91 | 2.5% | $560.12m | |
| VRTX | Vertex Pharmaceuticals, Inc. | 0.12% | 284.96 | 1.9% | $540.88m | |
| NVAX | Novavax, Inc. | -7.91% | 46.11 | 102.0% | $530.71m | |
| BIIB | Biogen, Inc. | 0.02% | 304.53 | 1.6% | $447.72m | |
| ILMN | Illumina, Inc. | 1.51% | 354.70 | 3.5% | $344.73m | |
| SRNE | Sorrento Therapeutics, Inc. | 0.80% | 5.07 | 1.8% | $271.93m | |
| SGEN | Seattle Genetics, Inc. | 1.02% | 155.77 | 6.1% | $227.64m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 0.36% | 101.50 | 2.0% | $215.96m | |
| CODX | Co-Diagnostics, Inc. | 2.94% | 18.55 | 0.0% | $192.06m | |
| A | Agilent Technologies, Inc. | 5.24% | 84.98 | 1.6% | $187.17m | |
| IMMU | Immunomedics, Inc. | -0.69% | 34.47 | 11.0% | $184.11m | |
| MGNX | MacroGenics, Inc. | 0.84% | 25.37 | 6.2% | $182.51m |
Company Profile
Esperion Therapeutics, Inc. engages in the development and commercialization of oral therapies for the treatment of patients with elevated low-density lipoprotein cholesterol. It offers NEXLETOL (bempedoic acid) tablets, and NEXLIZET (bempedoic acid and ezetimibe) tablets. The company was founded by Roger S. Newton, Hans Ageland, Jan O. Johansson, Anders Paul Wiklund, Michael E. Pape, David I. Scheer and Charles L. Bisgaier in May 1998 and is headquartered in Ann Arbor, MI.